However, no alterations in AKT phosphorylation were observed, suggesting that the pro-survival AKT pathway is the direct target of ANKRD17 instead of DDR1. These data suggest DDR1 may be the potential key component of ANKRD17-related metastasis in HCC. The gene discussed is AKT1; the disease is hepatocellular carcinoma.